What is Kings Pharmacy?
With a legacy spanning nearly seven decades, Kings Pharmacy has established itself as a cornerstone of professional pharmaceutical care. The company distinguishes itself through a patient-centric model that integrates high-touch service with innovative pharmacy practices. Recognized by the Arnold and Marie Schwartz College of Pharmacy at Long Island University, the firm maintains a reputation for clinical excellence and community engagement, notably through its dedicated residency program. This operational maturity provides a stable foundation for its current scaling efforts in a competitive healthcare landscape.
How much funding has Kings Pharmacy raised?
Kings Pharmacy has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Kings Pharmacy
PPP
Public-Private Partnership
What's next for Kings Pharmacy?
The recent infusion of capital is expected to catalyze the next phase of the company's evolution, focusing on the modernization of its service delivery and the potential expansion of its community residency footprint. As the firm navigates the complexities of late-stage growth, the strategic deployment of these funds will likely prioritize technological integration and the enhancement of patient satisfaction metrics. By maintaining its commitment to professional, on-site management, Kings Pharmacy is well-positioned to leverage this financial backing to solidify its market share and continue its trajectory of long-term, sustainable growth within the regional healthcare ecosystem.
See full Kings Pharmacy company page
